90‐Day all‐cause mortality can be predicted following a total knee replacement: an international, network study to develop and validate a prediction model
Authors:
- The OHDSI/EHDEN Knee Arthroplasty GroupTGThe OHDSI/EHDEN Knee Arthroplasty Group
- Daniel Prieto‐AlhambraDPDaniel Prieto‐Alhambra
Open Access
- 6 December 2021
- journal article
- research article
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 30 (9) , 3068-3075
Abstract
Purpose: The purpose of this study was to develop and validate a prediction model for 90‐day mortality following a total knee replacement (TKR). TKR is a safe and cost‐effective surgical procedure for treating severe knee osteoarthritis (OA). Although complications following surgery are rare, prediction tools could help identify high‐risk patients who could be targeted with preventative interventions. The aim was to develop and validate a simple model to help inform treatment choices.Methods: A mortality prediction model for knee OA patients following TKR was developed and externally validated using a US claims database and a UK general practice database. The target population consisted of patients undergoing a primary TKR for knee OA, aged ≥ 40 years and registered for ≥ 1 year before surgery. LASSO logistic regression models were developed for post‐operative (90‐day) mortality. A second mortality model was developed with a reduced feature set to increase interpretability and usability.Results: A total of 193,615 patients were included, with 40,950 in The Health Improvement Network (THIN) database and 152,665 in Optum. The full model predicting 90‐day mortality yielded AUROC of 0.78 when trained in OPTUM and 0.70 when externally validated on THIN. The 12 variable model achieved internal AUROC of 0.77 and external AUROC of 0.71 in THIN.Conclusions: A simple prediction model based on sex, age, and 10 comorbidities that can identify patients at high risk of short‐term mortality following TKR was developed that demonstrated good, robust performance. The 12‐feature mortality model is easily implemented and the performance suggests it could be used to inform evidence based shared decision‐making prior to surgery and targeting prophylaxis for those at high risk.Level of evidence: III.Keywords
Funding Information
- Innovative Medicines Initiative (806968)
- European Federation of Pharmaceutical Industries and Associations
- the innovative medicines initiative 2 joint (806968)
- The European Union’s Horizon 2020
- EFPIA
This publication has 17 references indexed in Scilit:
- Evaluation of three co-morbidity measures to predict mortality in patients undergoing total joint arthroplastyOsteoarthritis and Cartilage, 2016
- Risk Assessment Tools Used to Predict Outcomes of Total Hip and Total Knee ArthroplastyOrthopedic Clinics of North America, 2015
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and ElaborationAnnals of Internal Medicine, 2015
- 45-day mortality after 467 779 knee replacements for osteoarthritis from the National Joint Registry for England and Wales: an observational studyThe Lancet, 2014
- Predicting 3-Year Mortality After Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2014
- Massive Parallelization of Serial Inference Algorithms for a Complex Generalized Linear ModelACM Transactions on Modeling and Computer Simulation, 2013
- Mortality after surgery in Europe: a 7 day cohort studyThe Lancet, 2012
- Validation of a common data model for active safety surveillance researchJournal of the American Medical Informatics Association, 2012
- Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality ratesJournal of Innovation in Health Informatics, 2011
- Systematic Review: Prediction of Perioperative Cardiac Complications and Mortality by the Revised Cardiac Risk IndexAnnals of Internal Medicine, 2010